Solana Company (HSDT)
NASDAQ:HSDT
Want to see HSDT full AI Analyst Report?
HSDT Stock Chart & Stats
$2.12
-$0.04(-5.47%)
At close: 4:00 PM EST
$2.12
-$0.04(-5.47%)
Day’s Range― - ―
52-Week Range$1.59 - $265.50
Previous CloseN/A
Volume68.49K
Average Volume (3M)1.55M
Market Cap
$106.77M
Enterprise Value$78.15M
Total Cash (Recent Filing)$7.28M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.13
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.25
Shares Outstanding55,034,046
10 Day Avg. Volume1,311,391
30 Day Avg. Volume1,547,142
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.21
Price to Sales (P/S)10.59
P/FCF Ratio-1.04
Enterprise Value/Market Cap0.73
Enterprise Value/Revenue12.99
Enterprise Value/Gross Profit14.17
Enterprise Value/Ebitda-1.94
Forecast
1Y Price Target
$4.00Price Target Upside88.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-64.5
Revenue Forecast (FY)$655.00K
Bulls Say, Bears Say
Bulls Say
Clinical ResultsHSDT announced positive results from the PoNS Therapeutic Experience Program, or PoNSTEP, study for people with multiple sclerosis.
Partnerships And ApprovalsUnitedHealthcare has approved reimbursement for the PoNS device, adding a second private payer to provide coverage.
Bears Say
Financial PerformanceHSDT reported lower-than-expected 1Q25 revenue, as adoption of the PoNS device remains inconsistent.
Reimbursement ChallengesThe ongoing reimbursement headwind continues to limit access to key patient populations and suppress near-term growth.
Solana Company News
HSDT FAQ
What was Solana Company’s price range in the past 12 months?
Solana Company lowest stock price was $1.59 and its highest was $265.50 in the past 12 months.
What is Solana Company’s market cap?
Solana Company’s market cap is $106.77M.
When is Solana Company’s upcoming earnings report date?
Solana Company’s upcoming earnings report date is May 07, 2026 which is in 17 days.
How were Solana Company’s earnings last quarter?
Solana Company released its earnings results on Mar 30, 2026. The company reported $4.25 earnings per share for the quarter, beating the consensus estimate of N/A by $4.25.
Is Solana Company overvalued?
According to Wall Street analysts Solana Company’s price is currently Undervalued.
Does Solana Company pay dividends?
Solana Company does not currently pay dividends.
What is Solana Company’s EPS estimate?
Solana Company’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Solana Company have?
Solana Company has 55,034,046 shares outstanding.
What happened to Solana Company’s price movement after its last earnings report?
Solana Company reported an EPS of $4.25 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.989%.
Which hedge fund is a major shareholder of Solana Company?
Currently, no hedge funds are holding shares in HSDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Solana Company Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (88.68% Upside)
$4.00 (88.68% Upside)
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days >0.1%
Last 30 Days >0.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-98.11%
12-Months-Change
Fundamentals
Return on Equity
1028.60%
Trailing 12-Months
Asset Growth
8421.40%
Trailing 12-Months
Company Description
Solana Company
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
HSDT Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive operational progress story: strong staking performance (outperforming benchmarks), rapid revenue growth from staking, SOL-per-share accretion (+14% over six months), meaningful treasury and asset base, and strategic partnerships/infrastructure initiatives that position the company for future yield and ecosystem growth. Offsetting these positives are large GAAP operating losses driven by substantial noncash digital asset markdowns, a spike in SG&A/operating costs, modest cash on hand, and earnings volatility—Q4 profitability was driven largely by a one-time derivative fair-value gain. Anchor/Kamino borrowing and Pacific Backbone are strategic positives but not yet fully monetized. Overall, operational and strategic momentum is clear, but financial statement volatility, liquidity and execution timing risks temper the near-term outlook.View all HSDT earnings summariesHSDT Stock 12 Month Forecast
Average Price Target
$4.00
▲(88.68% Upside)
Technical Analysis
Ownership Overview
0.72% Insiders
0.64% Mutual Funds
0.05% Other Institutional Investors
98.00% Public Companies and
Individual Investors